Tilla S. Worgall, MD

Board Certifications: 
Clinical Pathology
Accepting New Patients
Profile Headshot

Overview

Areas of Expertise / Conditions Treated

Inborn Error of Metabolism, Multiple Myeloma

Academic Appointments

  • Associate Professor of Pathology & Cell Biology at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • HMO
  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • Blue Priority
  • EPO
  • HMO
  • Medicare (Mediblue)
  • NYP Employee Plan
  • Pathway (Exchange)
  • POS
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

Oxford Health Plans

  • Freedom
  • Liberty
  • Medicare Managed Care

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • EPO
  • Essential Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • University of Heidelberg, Faculty of Medicine (Germany)
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Residency: J Wolfgang Goethe University - Frankfurt
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Board Certifications

  • Clinical Pathology

Research

Selected Publications

Worgall, T.S., Veerappan, A., Sung, B., Kim, B.I., Weiner, E., Bholah, R., Silver, R.B., Jiang, X.C., and Worgall, S.. Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity. Sci Transl Med 2013 5:186ra167

Hornemann T, Worgall TS. Sphingolipids and atherosclerosis. Atherosclerosis 2013; 226: 16-28

Xu, Y., Krause, A., Limberis, M., Worgall, T.S., and Worgall, S. 2013. Low sphingosine-1-phosphate impairs lung dendritic cells in cystic fibrosis. Am J Respir Cell Mol Biol 2013 48:250-257.

Stojanovic, M.N., and Worgall, T.S.. Detecting hydrophobic molecules with nucleic acid-based receptors. Curr Opin Chem Biol, 2010 14:751-757

Pei R, Shen Aa, Olah MJ, Stefanovic D, Worgall TS, Stojanovic MN. 2009. High-resolution cross-reactive array for alkaloids. Chem Commun (Camb). 2009 Jun 14;(22):3193-5

Chang CL, Seo T, Matsuzaki M, Worgall TS, Deckelbaum RJ. 2009. N-3 fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution. Arterioscler Thromb Vasc Biol. 29: 555-61.

Hamai H, Keyserman F, Quittell LM, Worgall TS. 2009. Defective CFTR increases synthesis and mass of sphingolipids that modulate membrane composition and lipid signaling. J Lipid Res. 50: 1101-8.